136 related articles for article (PubMed ID: 24598656)
1. [Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection].
Ping LY; Ding N; Shi YF; Sun L; Zheng W; Xie Y; Wang XP; Tu MF; Lin NJ; Ying ZT; Liu WP; Deng LJ; Zhan C; Tian L; Feng LX; Song YQ; Zhu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):78-84. PubMed ID: 24598656
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
[TBL] [Abstract][Full Text] [Related]
3. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
[TBL] [Abstract][Full Text] [Related]
4. CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients.
Antel K; Chetty D; Oosthuizen J; Mohamed Z; Van der Vyver L; Verburgh E
Pathology; 2021 Aug; 53(5):628-634. PubMed ID: 33558066
[TBL] [Abstract][Full Text] [Related]
5. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining.
Ishtiaq S; Hassan U; Mushtaq S; Akhtar N
Asian Pac J Cancer Prev; 2013; 14(6):3963-7. PubMed ID: 23886215
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital.
Karnik S; Srinivasan B; Nair S
Pathology; 2003 Jun; 35(3):207-11. PubMed ID: 14506963
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma.
Chang KC; Chen PC; Chang Y; Wu YH; Chen YP; Lai CH; Medeiros LJ; Su IJ; Wang HW
Histopathology; 2017 Feb; 70(3):442-455. PubMed ID: 27632954
[TBL] [Abstract][Full Text] [Related]
8. [Epstein-Barr virus infection and expression of latent membrane protein 2A in Hodgkin's lymphoma of Uygur patients].
Li X; Yang SE; Guo YQ; Zang SH; Guo L; Gulikezi W; Zhao B; Liu W; Bai JP
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):239-42. PubMed ID: 23928530
[TBL] [Abstract][Full Text] [Related]
9. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
[TBL] [Abstract][Full Text] [Related]
10. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus and Hodgkin's lymphoma.
Andersson J
Herpes; 2006 May; 13(1):12-6. PubMed ID: 16732997
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus in biopsies from patients with Hodgkin and non-Hodgkin lymphoma at the University of Puerto Rico immunohistochemistry laboratory.
Córdova Pérez FJ; González-Keelan CI; Vélez R
P R Health Sci J; 2003 Jun; 22(2):125-9. PubMed ID: 12866135
[TBL] [Abstract][Full Text] [Related]
13. Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival.
Amini RM; Enblad G; Engström P; Christensson B; Glimelius B; Sundström C
Leuk Lymphoma; 2002 Jun; 43(6):1253-60. PubMed ID: 12152993
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma.
Mavili HS; Isisag A; Tan A; Miskioglu M; Baraz LS; Nese N
Turk Patoloji Derg; 2021; 37(2):130-138. PubMed ID: 33085074
[TBL] [Abstract][Full Text] [Related]
15. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
16. [Infection status and prognostic significance analysis of Epstein-Barr virus in 207 cases with newly diagnosed Hodgkin's lymphoma].
Kang S; Qin Y; He X; Zhou S; Han X; Liu P; Dong M; Zhou L; Yang J; Yang S; Zhang C; Gui L; Shi Y
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2594-8. PubMed ID: 26711606
[TBL] [Abstract][Full Text] [Related]
17. Epstein Barr virus latent membrane protein-1 in Hodgkin's lymphoma in Nigerians.
Adelusola KA; Titiloye NA; Rotimi O; Durosinmi M
Afr Health Sci; 2009 Sep; 9(3):174-8. PubMed ID: 20589147
[TBL] [Abstract][Full Text] [Related]
18. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease.
Delsol G; Brousset P; Chittal S; Rigal-Huguet F
Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829
[TBL] [Abstract][Full Text] [Related]
19. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
20. The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt.
Mohamed O; El Bastawisy A; Allahlobi N; Abdellateif MS; Zekri ARN; Shaarawy S; Korany Z; Mohanad M; Bahnassy AA
Diagn Pathol; 2020 Feb; 15(1):10. PubMed ID: 32019558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
